Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.

Lin DW. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA. Urol Oncol. 2009 May-Jun; 27(3):315-21.

View in: PubMed

subject areas

Antigens, Neoplasm
Biomarkers, Tumor
DNA Methylation
Humans
Male
Oncogene Proteins, Fusion
Prostate-Specific Antigen
Prostatic Neoplasms
Sensitivity and Specificity

authors with profiles

Daniel Lin

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement